Skip to main content
Merck-backed startup makes progress on blood test for cancer

The results of a study being published in the New England Journal of Medicine are favorable toward a blood test that helps doctors detect a particular type of cancer -- a good sign for biotech startup Grail as it further develops the test. The startup's investors include pharmaceutical company Merck and China's Tencent, as well as Bill Gates and Jeff Bezos.

Full Story: